Literature DB >> 4607088

Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.

H Pakkenberg, R Fog.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4607088     DOI: 10.1001/archneur.1974.00490410100014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  8 in total

1.  Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.

Authors:  Itzhak Kimiagar; Evgenia Dobronevsky; Tatiana Prokhorov; Ala Miniovitz; Jose M Rabey
Journal:  J Neurol       Date:  2011-11-09       Impact factor: 4.849

Review 2.  Do neuroleptic drugs still have a place in neurological therapy?

Authors:  T Klockgether; J Dichgans
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

Review 3.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

Review 4.  Treatment strategies for dystonia.

Authors:  Leslie J Cloud; H A Jinnah
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

Review 5.  Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.

Authors:  R M Pinder; R N Brogden; R Swayer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.

Authors:  M Bartels; E Zeller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

7.  Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome.

Authors:  L Regeur; B Pakkenberg; R Fog; H Pakkenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-07       Impact factor: 10.154

8.  Clinical aspects of dyskinesia.

Authors:  J Ananth
Journal:  Indian J Psychiatry       Date:  1980-07       Impact factor: 1.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.